Standardizing Healthcare Delivery to Reduce Utilization, the Potential of Evidence-Based Care Pathways

Overview

Journal Crohns Colitis 360

Publisher Oxford University Press

Date 2023 Feb 13

PMID 36777746

Authors

Edward L Barnes

Affiliations

Soon will be listed here.

References

Barnes E, Kochar B, Long M, Kappelman M, Martin C, Korzenik J . Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis. 2017; 23(6):875-881. PMC: 5512697. DOI: 10.1097/MIB.0000000000001121. View

Hwang C, Issokson K, Giguere-Rich C, Reddy S, Tinsley A, van Deen W . Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway. Clin Gastroenterol Hepatol. 2020; 18(12):2645-2649.e4. DOI: 10.1016/j.cgh.2020.06.039. View

Siegel C, Bernstein C . Identifying Patients With Inflammatory Bowel Diseases at High vs Low Risk of Complications. Clin Gastroenterol Hepatol. 2019; 18(6):1261-1267. DOI: 10.1016/j.cgh.2019.11.034. View

Regueiro M, Click B, Holder D, Shrank W, McAnallen S, Szigethy E . Constructing an Inflammatory Bowel Disease Patient-Centered Medical Home. Clin Gastroenterol Hepatol. 2017; 15(8):1148-1153.e4. DOI: 10.1016/j.cgh.2017.05.026. View

Szigethy E, Allen J, Reiss M, Cohen W, Perera L, Brillstein L . White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2017; 15(7):986-997. DOI: 10.1016/j.cgh.2017.02.037. View

Click B, Rivers C, Koutroubakis I, Babichenko D, Anderson A, Hashash J . Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016; 22(6):1442-9. PMC: 4868776. DOI: 10.1097/MIB.0000000000000763. View

Kochar B, Barnes E, Long M, Cushing K, Galanko J, Martin C . Depression Is Associated With More Aggressive Inflammatory Bowel Disease. Am J Gastroenterol. 2017; 113(1):80-85. PMC: 5962285. DOI: 10.1038/ajg.2017.423. View

Nguyen G, Loftus Jr E, Hirano I, Falck-Ytter Y, Singh S, Sultan S . American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection. Gastroenterology. 2016; 152(1):271-275. DOI: 10.1053/j.gastro.2016.10.038. View

Rubin D, Krugliak Cleveland N . Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease. Am J Gastroenterol. 2015; 110(9):1252-6. DOI: 10.1038/ajg.2015.86. View

10.

Lytvyak E, Sutton R, Dieleman L, Peerani F, Fedorak R, Kroeker K . Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization. Crohns Colitis 360. 2023; 2(4):otaa080. PMC: 9802474. DOI: 10.1093/crocol/otaa080. View

11.

Colombel J, DHaens G, Lee W, Petersson J, Panaccione R . Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis. 2019; 14(2):254-266. PMC: 7008150. DOI: 10.1093/ecco-jcc/jjz131. View

12.

Regueiro M, McAnallen S, Greer J, Perkins S, Ramalingam S, Szigethy E . The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care. Inflamm Bowel Dis. 2016; 22(8):1971-80. DOI: 10.1097/MIB.0000000000000819. View

13.

Regueiro M, Click B, Anderson A, Shrank W, Kogan J, McAnallen S . Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home. Clin Gastroenterol Hepatol. 2018; 16(11):1777-1785. PMC: 6185823. DOI: 10.1016/j.cgh.2018.04.007. View

14.

Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L . Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology. 2019; 157(1):242-254.e6. DOI: 10.1053/j.gastro.2019.03.064. View

15.

Cohen-Mekelburg S, Rosenblatt R, Gold S, Shen N, Fortune B, Waljee A . Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes. Am J Gastroenterol. 2018; 114(2):276-290. DOI: 10.1038/s41395-018-0417-9. View

16.

Siegel C . Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options. Gut. 2011; 61(3):459-65. DOI: 10.1136/gutjnl-2011-300988. View

17.

Ungaro R, Colombel J, Lissoos T, Peyrin-Biroulet L . A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. Am J Gastroenterol. 2019; 114(6):874-883. PMC: 6553548. DOI: 10.14309/ajg.0000000000000183. View

18.

Nguyen G, Bouchard S, Diong C . Access to Specialists and Emergency Department Visits in Inflammatory Bowel Disease: A Population-Based Study. J Crohns Colitis. 2018; 13(3):330-336. DOI: 10.1093/ecco-jcc/jjy161. View